[
  {
    "Company": "AlveoliX",
    "Model": "AX12 Alveolus-on-Chip (Healthy Baseline)",
    "Organs/Tissues": "Human lung alveolar barrier (type I/II epithelium + endothelium)",
    "Physiological/Pathological": "Physiological (normal alveolar function, gas exchange)",
    "Cell Source": "Primary alveolar epithelial cells (Type I/II), primary lung endothelial cells",
    "Multiple Cell Types": "Yes (epithelium + endothelium), immune optional",
    "Stromal Cells": "Not by default (very thin barrier), fibroblasts can be added in endothelial channel",
    "Tissue-resident Immune": "Optional alveolar macrophages if desired",
    "Circulating Immune": "Yes, immune cells can flow through endothelial channel",
    "Crosstalk (Multi-tissue)": "No, single organ (alveolus)",
    "Air-Liquid Interface": "Yes (key alveolar feature)",
    "Extracellular Matrix": "Yes (ECM-coated flexible membrane)",
    "3D Scaffold": "Yes (stretchable membrane providing 3D mechanical environment)",
    "Notable Features": "Cyclic 'breathing' motion (~8% stretch), TEER measurement, multi-week ALI culture",
    "Plate/Format (Throughput)": "AX12 plate (12 independent units), medium throughput, 96-well footprint size",
    "Max Culture Duration": "Up to ~3+ weeks with stable ALI",
    "Readouts - Live Imaging": "Yes (transparent plate, confocal/fluorescence)",
    "Readouts - Supernatant Sampling": "Yes (endothelial channel)",
    "Readouts - Cell Retrieval": "Yes (both sides of membrane for flow cytometry/qPCR)",
    "Readouts - Whole Tissue": "Yes (membrane fix, histology, EM)",
    "Readouts - TEER": "Yes (integrated electrodes)",
    "Readouts - MEA": "No (not for lung tissue)",
    "Readouts - Integrated Biosensors": "TEER electrode system, no built-in chemical sensor",
    "Dead Volume": "Minimal (small micro-chamber design)",
    "Perfused": "Passive or intermittent flow in endothelial channel, not continuous",
    "Gas Mix Controlled": "Via incubator (air or custom gas over ALI side)",
    "Real-time Microenvironment Control": "Yes, can adjust breathing motion/flow, add immune cells, etc.",
    "model_availability": "Both (product: AX12 system + possible support services)"
  },
  {
    "Company": "AlveoliX",
    "Model": "AX12 Alveolus-on-Chip (Inflammation/Fibrosis Model)",
    "Organs/Tissues": "Human lung alveolar barrier with induced pathological state (inflammation, fibrotic changes)",
    "Physiological/Pathological": "Pathological – e.g. inflammatory or fibrotic alveolus",
    "Cell Source": "Same primary alveolar epithelium + endothelium, with pro-fibrotic or pro-inflammatory stimuli, optional immune cells",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "Fibroblasts may be included to model fibrosis",
    "Tissue-resident Immune": "Yes if macrophages are added",
    "Circulating Immune": "Yes (perfusing immune cells to mimic infiltration)",
    "Crosstalk (Multi-tissue)": "No, single alveolar compartment",
    "Air-Liquid Interface": "Yes",
    "Extracellular Matrix": "Yes",
    "3D Scaffold": "Yes (membrane + breathing motion)",
    "Notable Features": "Mimics diseased lung environment (e.g. TGF-β-induced fibrosis, cytokine-driven inflammation), real-time TEER to track barrier disruption",
    "Plate/Format (Throughput)": "AX12 (12 units), medium throughput",
    "Max Culture Duration": "Weeks (depends on disease induction)",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Yes",
    "Readouts - Whole Tissue": "Yes",
    "Readouts - TEER": "Yes",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "TEER electrodes; no O2 sensor integrated",
    "Dead Volume": "Minimal",
    "Perfused": "Intermittent or partial flow via AX Exchanger",
    "Gas Mix Controlled": "Incubator-based or user-defined for ALI side",
    "Real-time Microenvironment Control": "Yes (adjust mechanical stretch, medium flow, immune addition)",
    "model_availability": "Both (hardware + consulting for disease modeling)"
  },
  {
    "Company": "AlveoliX",
    "Model": "AX12 Alveolus-on-Chip (Immune Infiltration Variant)",
    "Organs/Tissues": "Human alveolar interface with integrated immune components",
    "Physiological/Pathological": "Can simulate infection or inflammation with active immune cell recruitment",
    "Cell Source": "Primary alveolar epithelial/endothelial + alveolar macrophages in apical side + circulating leukocytes in perfusion channel",
    "Multiple Cell Types": "Yes (epithelium, endothelium, macrophages, added T-cells/neutrophils)",
    "Stromal Cells": "Optional fibroblasts if desired",
    "Tissue-resident Immune": "Yes (macrophages at ALI)",
    "Circulating Immune": "Yes (introduced in endothelial flow to study transmigration)",
    "Crosstalk (Multi-tissue)": "No",
    "Air-Liquid Interface": "Yes",
    "Extracellular Matrix": "Yes (membrane coating)",
    "3D Scaffold": "Yes (membrane + mechanical stretch)",
    "Notable Features": "Study immune-cell extravasation, alveolar inflammation, cytokine release under breathing motions",
    "Plate/Format (Throughput)": "AX12 chip (12 units), moderate throughput",
    "Max Culture Duration": "Up to ~3 weeks, depends on immune cell viability",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Yes (macrophages, T-cells can be recovered)",
    "Readouts - Whole Tissue": "Yes (membrane-based histology/IF)",
    "Readouts - TEER": "Yes (barrier integrity checks)",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "TEER measurement, no chemical sensors",
    "Dead Volume": "Minimal",
    "Perfused": "Periodic or partial flow in vascular channel",
    "Gas Mix Controlled": "Incubator or custom input for ALI side",
    "Real-time Microenvironment Control": "Yes, can dynamically add immune cells, modulate stretch",
    "model_availability": "Both (product + support services)"
  }
]
